Login to Your Account



China’s Fosun moves into India with offer to acquire Gland for $1.3B

By T.V. Padma and Cornelia Zou
Staff Writers

Thursday, July 28, 2016

NEW DELHI – In what may end up as a landmark $1.3 billion deal, China’s Shanghai Fosun Pharmaceutical (Group) Ltd. is set to acquire Indian injectables specialist Gland Pharma Ltd.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription